FGF21 and Huntington disease: Finally, due to the trial design, we cannot draw firm conclusions about whether serum FGF21 plays a causal role in the outcome among HD patients and we cannot clarify the exact pathophysiological mechanisms of FGF21 in ESKD and its complications.